34457261|t|Molecular mechanisms of lidocaine.
34457261|a|Lidocaine is an amide-class local anesthetic used clinically to inhibit pain sensations. Systemic administration of lidocaine has antinociceptive, antiarrhythmic, anti-inflammatory, and antithrombotic effects. Lidocaine exerts these effects under both acute and chronic pain conditions and acute respiratory distress syndrome through mechanisms that can be independent of its primary mechanism of action, sodium channel inhibition. Here we review the pathophysiological underpinnings of lidocaine's role as an anti-nociceptive, anti-inflammatory mediated by toll-like receptor (TLR) and nuclear factor kappa-beta (NF-kbeta) signalling pathways and downstream cytokine effectors high mobility group box 1 (HMGB1) and tumour necrosis factor-alpha (TNF-alpha).
34457261	24	33	lidocaine	Chemical	MESH:D008012
34457261	35	44	Lidocaine	Chemical	MESH:D008012
34457261	51	56	amide	Chemical	MESH:D000577
34457261	107	111	pain	Disease	MESH:D010146
34457261	151	160	lidocaine	Chemical	MESH:D008012
34457261	203	215	inflammatory	Disease	MESH:D007249
34457261	245	254	Lidocaine	Chemical	MESH:D008012
34457261	287	320	acute and chronic pain conditions	Disease	MESH:D059787
34457261	325	360	acute respiratory distress syndrome	Disease	MESH:D012128
34457261	440	446	sodium	Chemical	MESH:D012964
34457261	522	531	lidocaine	Chemical	MESH:D008012
34457261	550	561	nociceptive	Disease	MESH:D059226
34457261	568	580	inflammatory	Disease	MESH:D007249
34457261	713	738	high mobility group box 1	Gene	3146
34457261	740	745	HMGB1	Gene	3146
34457261	781	790	TNF-alpha	Gene	7124
34457261	Association	MESH:D008012	3146
34457261	Negative_Correlation	MESH:D008012	MESH:D059787
34457261	Negative_Correlation	MESH:D008012	MESH:D007249
34457261	Positive_Correlation	MESH:D008012	MESH:D012128
34457261	Negative_Correlation	MESH:D008012	MESH:D010146
34457261	Association	MESH:D008012	7124
34457261	Negative_Correlation	MESH:D008012	MESH:D059226
34457261	Negative_Correlation	MESH:D008012	MESH:D012964

